EUVIMEDEUVIMED entdecken
Crossref

4-(3-Phenylsulfonylindol-2-yl)-1-(pyridin-2-yl)piperazinyl-methanones as Potent Inhibitors of both SARS-CoV-2 and HCoV-OC43 Viruses

Michela Puxeddu iD, Manuela Donalisio iD, Joachim Jakob Bugert, Angela Corona iD, Paolo Cocomazzi, Mario Milani, Friederike Hucke, Irene Arduino, Francesca Esposito, Paolo Moretti, Maria Grazia Ortore iD, Marianna Nalli und 13 weitere

ACS Infectious Diseases · 2024

DOI: 10.1021/acsinfecdis.4c00108 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, 2024. Verfasst von Michela Puxeddu und 24 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Affiliated to Istituto Pasteur Italia - Fondazione Cenci Bolognetti, Department of Drug Chemistry and Technologies, Sapienza University of…. Hauptthemen laut MEDLINE: SARS-CoV-2, Antiviral Agents, Coronavirus OC43, Human. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: European Commission, Ministero dell?Istruzione, dell?Universit? e della Ricerca, Sapienza Universit? di Roma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2Antiviral AgentsCoronavirus OC43, HumanHumansChlorocebus aethiopsAnimalsVero CellsCoronavirus 3C ProteasesCOVID-19 Drug TreatmentCOVID-19Cell Line

Stichwörter der Autor:innen

3CL proteaseHCoV-OC43SARS-CoV-2antiviral drugssynthesis

Substanzen

Antiviral AgentsCoronavirus 3C Proteases

Autor:innen und Institutionen

  • Laboratory Affiliated to Istituto Pasteur Italia - Fondazione Cenci Bolognetti, Department of Drug Chemistry and Technologies, Sapienza University of Rome, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
  • Department of Clinical and Biological Sciences, University of Turin, Regione Gonzole 10, I-10043 Orbassano, Turin, Italy.
  • Institut für Mikrobiologie der Bundeswehr, Neuherbergstrasse 11, D-80937 München, Germany.
  • Department of Life and Environmental Sciences, University of Cagliari, S.P. 8 Monserrato, Sestu Km 0.700, I-09042 Monserrato, Italy.
  • Biophysics Institute, CNR-IBF, Via Corti 12, I-20133 Milan, Italy.
  • DISVA, Department of Life Sciences and Environment, Università Politecnica delle Marche, Via Brecce Bianche, I-60131 Ancona, Italy.

ORCID-Profile: Michela Puxeddu, Manuela Donalisio, Angela Corona, Maria Grazia Ortore, Giulia Mazzoccanti, Giulio Dondio, Antonio Coluccia, David Lembo, Romano Silvestri, Eloise Mastrangelo, Giuseppe La Regina

Förderung

  • European Commission
  • Ministero dell?Istruzione, dell?Universit? e della Ricerca
  • Sapienza Universit? di Roma
  • Associazione Italiana per la Ricerca sul Cancro
  • Bundeswehr Medical Service

Zitieren

APA

Puxeddu, M., Donalisio, M., Bugert, J. J., Corona, A., Cocomazzi, P., Milani, M., Hucke, F., Arduino, I., Esposito, F., Moretti, P., Ortore, M. G., Nalli, M., Manetto, S., Mazzoccanti, G., Bigogno, C., Dondio, G., Sciò, P., Coluccia, A., Fracella, M., …, & La Regina, G. (2024). 4-(3-Phenylsulfonylindol-2-yl)-1-(pyridin-2-yl)piperazinyl-methanones as Potent Inhibitors of both SARS-CoV-2 and HCoV-OC43 Viruses. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.4c00108

Vancouver

Puxeddu M, Donalisio M, Bugert JJ, Corona A, Cocomazzi P, Milani M, et al. 4-(3-Phenylsulfonylindol-2-yl)-1-(pyridin-2-yl)piperazinyl-methanones as Potent Inhibitors of both SARS-CoV-2 and HCoV-OC43 Viruses. ACS Infectious Diseases. 2024. doi:10.1021/acsinfecdis.4c00108

BibTeX
@article{Puxeddu2024,
  author = {Puxeddu, Michela and Donalisio, Manuela and Bugert, Joachim Jakob and Corona, Angela and Cocomazzi, Paolo and Milani, Mario and Hucke, Friederike and Arduino, Irene and Esposito, Francesca and Moretti, Paolo and Ortore, Maria Grazia and Nalli, Marianna and Manetto, Simone and Mazzoccanti, Giulia and Bigogno, Chiara and Dondio, Giulio and Sciò, Pietro and Coluccia, Antonio and Fracella, Matteo and Antonelli, Guido and Lembo, David and Tramontano, Enzo and Silvestri, Romano and Mastrangelo, Eloise and La Regina, Giuseppe},
  title = {4-(3-Phenylsulfonylindol-2-yl)-1-(pyridin-2-yl)piperazinyl-methanones as Potent Inhibitors of both SARS-CoV-2 and HCoV-OC43 Viruses},
  journal = {ACS Infectious Diseases},
  year = {2024},
  doi = {10.1021/acsinfecdis.4c00108}
}
Kostenlos starten →